Micrel asks shareholders not to let Obrem Capital take control at special meeting on May 20

By Lisa Kerner

Charlotte, N.C., April 15 - Micrel, Inc. is soliciting proxies against proposals submitted by Obrem Capital Management, LLC and its affiliates, it was reported in a schedule 14A filed with the Securities and Exchange Commission.

According to Micrel, Obrem, a 14.9% shareholder, is attempting to take control of Micrel's board of directors in order to force a sale of the company.

Obrem called for the special meeting to be held by Micrel on May 20.

As previously reported Obrem filed preliminary proxy statement soliciting proxies in an attempt to:

• Remove Micrel's five current directors;

• Amend Micrel's bylaws to permit shareholders to fix the number of directors to a range of not less than four and not more than seven directors;

• Amend Micrel's bylaws to establish the number of directors at six;

• Elect six nominees proposed by Obrem to fill the six seats on the board; and

• Approve a non-binding shareholder resolution recommending that the board rescind the shareholder rights plan adopted by Micrel on March 28.

Micrel asked its shareholders to reject the first, second, third and fifth Obrem proposals. Obrem's fourth proposal will have no effect if Obrem's first three proposals are not adopted, the filing said.

If its proposals are accepted by Micrel shareholders, Obrem intends to ask that directors have Micrel engage an investment bank with semiconductor industry expertise to pursue a sale of the company, a prior SEC filing said.

On April 1, Micrel sent an open letter to stockholders refuting what the company called Obrem's "inaccurate and self-serving assertions."

Micrel's letter accused Obrem, a very recent Micrel investor, of using a "cherry-picked" set of comparables to make its case against Micrel.

While Micrel introduced 82 new products in 2007 and amassed a large patent portfolio, the company admitted the potential of these products is not reflected in Micrel's stock price.

Obrem, in its own April 1 open letter to Micrel stockholders, said it was disappointed that Micrel management chose to "attack" Obrem rather than address what the investor said is its primary concern: creating permanent value for stockholders.

The investor accused Micrel of improperly blaming the semiconductor market conditions for its ongoing underperformance, citing the strength of the analog semiconductor industry over the past five years, and stood by its claim that Micrel's operating performance lags its peer group.

Obrem also denied any attempt to remove Micrel chief executive officer Ray Zinn but added that during the past 10 years under Zinn's leadership, "there has been a decrease in Micrel's share price and no tangible value creation for stockholders."

Obrem's nominees for election to the Micrel board are:

• Bill Bradford, a co-founder and general partner of Saguaro Ventures;

• Keith R. Gollust, a founding partner of Gollust, Tierney, and Oliver, a private investment firm;

• Eric Gomberg, a senior investment analyst at Obrem Capital Management;

• Ben Goren, a principal at GCG Capital;

• Keith M. Kolerus, former chairman of the board of ACI Electronics; and

• Andrew Rechtschaffen, founder and managing member of Obrem Capital Management.

Micrel develops and manufactures high-performance analog power integrated circuits (ICs), mixed-signal ICs and digital ICs. The company is based in San Jose, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.